WEKO3
アイテム
Consensus Statement on Proton Therapy in Mesothelioma
https://repo.qst.go.jp/records/81646
https://repo.qst.go.jp/records/81646a8243487-0747-4f50-a322-d298f0928168
| Item type | 学術雑誌論文 / Journal Article(1) | |||||
|---|---|---|---|---|---|---|
| 公開日 | 2020-09-30 | |||||
| タイトル | ||||||
| タイトル | Consensus Statement on Proton Therapy in Mesothelioma | |||||
| 言語 | ||||||
| 言語 | eng | |||||
| 資源タイプ | ||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
| 資源タイプ | journal article | |||||
| アクセス権 | ||||||
| アクセス権 | metadata only access | |||||
| アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
| 著者 |
Zeng, Jing
× Zeng, Jing× N Badiyan, Shahed× I Garces, Yolanda× Wong, Tony× Zhang, Xiaodong× B Simone, Charles× Y Chang, Joe× C Knopf, Antje× Mori, Shinichiro× Iwata, Hiromitsu× Meijers, Arturs× Li, Heng× Bues, Martin× Liu, Wei× E Schild, Steven× Rengan, Ramesh× Shinichiro, Mori× Hiromitsu, Iwata |
|||||
| 抄録 | ||||||
| 内容記述タイプ | Abstract | |||||
| 内容記述 | Purpose: Radiation therapy for mesothelioma remains challenging, as normal tissue toxicity limits the amount of radiation that can be safely delivered to the pleural surfaces, especially radiation dose to the contralateral lung. The physical properties of proton therapy result in better sparing of normal tissues when treating the pleura, both in the postpneumonectomy setting and the lung-intact setting. Compared with photon radiation, there are dramatic reductions in dose to the contralateral lung, heart, liver, kidneys, and stomach. However, the tissue heterogeneity in the thorax, organ motion, and potential for changing anatomy during the treatment course all present challenges to optimal irradiation with protons. Methods: The clinical data underlying proton therapy in mesothelioma are reviewed here, including indications, advantages, and limitations. Results: The Particle Therapy Cooperative Group Thoracic Subcommittee task group provides specific guidelines for the use of proton therapy for mesothelioma. Conclusions: This consensus report can be used to guide clinical practice, insurance approval, and future research. |
|||||
| 書誌情報 |
Practical radiation oncology 巻 11, 号 2, p. 119-133, 発行日 2020-05 |
|||||
| 出版者 | ||||||
| 出版者 | Elsevier | |||||
| ISSN | ||||||
| 収録物識別子タイプ | ISSN | |||||
| 収録物識別子 | 1879-8500 | |||||
| PubMed番号 | ||||||
| 識別子タイプ | PMID | |||||
| 関連識別子 | 32461036 | |||||
| DOI | ||||||
| 識別子タイプ | DOI | |||||
| 関連識別子 | 10.1016/j.prro.2020.05.004 | |||||
| 関連サイト | ||||||
| 識別子タイプ | URI | |||||
| 関連識別子 | https://www.practicalradonc.org/article/S1879-8500(20)30117-X/fulltext | |||||
